Oruka Therapeutics (ORKA) Misses Q4 EPS by 45c
Oruka Therapeutics (NASDAQ: ORKA) reported Q4 EPS of ($0.45). Revenue for the quarter came in at $0.
For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.
Oruka Therapeutics (NASDAQ: ORKA) reported Q4 EPS of ($0.45). Revenue for the quarter came in at $0.
For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.